Giulia Francesca Manfredi

机构：Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Hammersmith Hospital, Ospedale di Cattinara, Azienda Ospedaliero Universitaria Maggiore della Carita, Azienda Ospedaliera Ospedale Maggiore · ORCID：0000-0002-2399-5376

发表论文 114 篇 · 总被引 822 次 · h-index 15

代表论文

• Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study (2025 · JHEP Reports · 被引 12)
• Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma (2025 · JAMA Oncology · 被引 9)
• Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world (2025 · JHEP Reports · 被引 5)
• A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma (2026 · Journal of Hepatology · 被引 2)
• The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study (2026 · The Lancet Digital Health · 被引 2)
• Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: Results of the DT-real study (2025 · JHEP Reports · 被引 2)